Pharma M&A
The latest news about Pharma M&A: headlines, AI summaries and the full story from every source.
- AmyriAD Therapeutics Acquires Recognify Life Sciences to Expand Cognition Pipeline
- BioMarin Acquires Alesta Therapeutics for $275M to Expand Rare Disease Pipeline
- Vertex Acquires Crinetics for $10 Billion; Viking Therapeutics Seen as Potential Next Target
- Avere Therapeutics to Go Public via Reverse Merger with NextCure, Advances Psoriasis Pill